Should Patents Create Incentives for Failure?
Scholar argues that patents do not—and should not—compensate for the costs of drug development.
Teaching Standard Essential Patents
In-depth course module opens the door for law students to the increasingly vital world of voluntary standards.
What It Means to Support a Waiver of COVID-19 Vaccine Patents
The Biden Administration should exert international and domestic pressure to waive COVID-19 vaccine patents.
Justice Department’s New Position on Patents, Standard Setting, and Injunctions
A new policy statement from the federal government contradicts established law on whether patent holders can seek injunctions.